Navigation Links
A molecule impedes the destruction of the 'Brucella' bacteria

Research carried out with the participation of the University of Navarra has shown how a determinate molecule helps an important pathogen, Brucella abortus, escape destruction within the cells charged with eliminating infectious agents (macrophages). This research has been published in Nature Immunology scientific magazine.

Brucella is a model of an intracellular parasite, a category that includes other important bacteria, such as those of tuberculosis or legionelosis. Brucella penetrates the macrophages within membranous vesicles that are not fused with lysosomes (structures containing cellular products necessary to destroy bacteria) as occurs in other micro-organisms. On the contrary, they reach certain compartments within the macrophage. Here the bacteria multiply and establish a chain of events that determine the illness.

Brucellosis, the illness caused by these bacteria, is of great importance worldwide, with millions of human beings and domestic animals affected. This discovery not only means new useful ideas for other researchers, but also the enhanced knowledge of a very important pathogen. From this knowledge useful products, such as new vaccines, can be derived.


'"/>

Source:Elhuyar Fundazioa


Page: 1

Related biology news :

1. Chemists create Superbowl molecule; May lead to better health
2. Key molecule in plant photo-protection identified
3. Inflammatory molecules released by pollen trigger allergies
4. Researchers discover molecule that causes secondary stroke
5. Yale researchers identify molecule for detecting parasitic infection in humans
6. Scientists identify molecule that regulates well-known tumor suppressor
7. Medical molecules designed to respond to visible light that can penetrate tissue
8. Researchers find promising cancer-fighting power of synthetic cell-signaling molecule
9. Chemists synthesize molecule that helps body battle cancers, malaria
10. DNA constraints control structure of attached macromolecules
11. Scripps research scientists identify infertility molecule
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/20/2016)... DALLAS , June 20, 2016 ... criminal justice technology solutions for public safety, investigation, ... by the prisons involved, it has secured the ... Corrections (DOC) facilities for Managed Access Systems (MAS) ... (4) additional facilities to be installed by October, ...
(Date:6/7/2016)... TORONTO , June 7, 2016  Syngrafii ... begun a business relationship that includes integrating Syngrafii,s ... pilot branch project. This collaboration will result in ... for the credit union, while maintaining existing document ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
(Date:6/1/2016)... -- Favorable Government Initiatives Coupled With Implementation ... to Boost Global Biometrics System Market Through 2021  ... " Global Biometrics Market By Type, By End ... - 2021", the global biometrics market is projected to ... growing security concerns across various end use sectors such ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... June 23, 2016 , ... UAS LifeSciences, one of the ... brand, UP4™ Probiotics, into Target stores nationwide. The company, which has been manufacturing ... to its list of well-respected retailers. This list includes such fine stores as ...
(Date:6/23/2016)... , June 23, 2016 Houston ... with the Cy-Fair Sports Association to serve as ... the agreement, Houston Methodist Willowbrook will provide sponsorship ... and connectivity with association coaches, volunteers, athletes and ... with the Cy-Fair Sports Association and to bring ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: